Sign in

CIK 0001034842

  • Accelerated filer

RIGEL PHARMACEUTICALS INC

Sign in to watch
Ticker
RIGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943248524
Phone
+1 650-624-1100
Business address
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
Former names
RIGEL PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-11-03 Maynard Ryan D EVP & CFO Exercise or conversion +100,000 $2.14 $214K 100,000
2017-11-03 Maynard Ryan D EVP & CFO Sale −100,000 $3.90 $390K 0
2017-11-03 Maynard Ryan D EVP & CFO Exercise or conversion · Employee Stock Option (right to buy) −100,000 75,000
2017-04-19 Maynard Ryan D EVP & CFO Grant or award · Employee Stock Option (Right to Buy) +62,500 62,500
2017-04-19 Maynard Ryan D EVP & CFO Grant or award · Employee Stock Option (Right to Buy) +150,000 150,000
2017-02-02 Maynard Ryan D EVP & CFO Grant or award · Stock Option (Right to Buy) +150,000 150,000
2016-04-04 Maynard Ryan D EVP & CFO Grant or award · Employee Stock Option (right to buy) +62,500 62,500
2016-04-04 Maynard Ryan D EVP & CFO Grant or award · Employee Stock Option (right to buy) +175,000 175,000
2016-01-26 Maynard Ryan D EVP & CFO Grant or award · Stock Option (Right to Buy) +150,000 150,000
2015-01-26 Maynard Ryan D EVP & CFO Grant or award · Stock Option (Right to Buy) +175,000 175,000
2014-02-27 Maynard Ryan D EVP & CFO Grant or award · Stock Option (Right to Buy) +125,000 125,000

Page 1 of 1 · 11 trades